Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS — Stella

Recruiting

Back to Schizophrenia and Related Disorders trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Netherlands

Amsterdam UMC, dept. Psychiatry, Amsterdam, North Holland

Key details

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborators

Parnassia Groep, The University of Texas at Dallas

Enrollment target

~24 participants

Started

December 2024

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov